These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 18596674)
1. Therapy for unresectable recurrent and in-transit extremity melanoma. Gimbel MI; Delman KA; Zager JS Cancer Control; 2008 Jul; 15(3):225-32. PubMed ID: 18596674 [TBL] [Abstract][Full Text] [Related]
2. Current treatment of locoregional recurrence of melanoma. Squires MH; Delman KA Curr Oncol Rep; 2013 Oct; 15(5):465-72. PubMed ID: 23907518 [TBL] [Abstract][Full Text] [Related]
3. Natural history and selective management of in transit melanoma. Wong JH; Cagle LA; Kopald KH; Swisher SG; Morton DL J Surg Oncol; 1990 Jul; 44(3):146-50. PubMed ID: 2370798 [TBL] [Abstract][Full Text] [Related]
4. Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma. Möller MG; Salwa S; Soden DM; O'Sullivan GC Expert Rev Anticancer Ther; 2009 Nov; 9(11):1611-30. PubMed ID: 19895245 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic hyperthermic limb perfusion in stage I melanoma. Krige JE; King HS; Strover RM Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834 [TBL] [Abstract][Full Text] [Related]
7. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma. Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586 [TBL] [Abstract][Full Text] [Related]
8. Improved survival of patients with stage II melanoma of the extremity using hyperthermic isolation perfusion with 1-phenylalanine mustard. Hartley JW; Fletcher WS J Surg Oncol; 1987 Nov; 36(3):170-4. PubMed ID: 3682836 [TBL] [Abstract][Full Text] [Related]
9. Commentary on pharmacotherapy of regional melanoma therapy. Zager JS; Delman KA Expert Opin Pharmacother; 2010 Jan; 11(1):1-3. PubMed ID: 20001424 [TBL] [Abstract][Full Text] [Related]
10. Management of in-transit metastases from cutaneous malignant melanoma. Hayes AJ; Clark MA; Harries M; Thomas JM Br J Surg; 2004 Jun; 91(6):673-82. PubMed ID: 15164434 [TBL] [Abstract][Full Text] [Related]
17. Alternatives for the treatment of local advanced disease: electrochemotherapy, limb perfusion, limb infusion, intralesional IL2. What is the role? Testori A; Intelisano A; Verrecchia F; Menicanti C; Tosti G; Grassi E; Pari C; Pennacchioli E Dermatol Ther; 2012; 25(5):443-51. PubMed ID: 23046023 [TBL] [Abstract][Full Text] [Related]
18. Isolated limb perfusion for unresectable melanoma of the extremities. Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572 [TBL] [Abstract][Full Text] [Related]
19. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma. Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694 [TBL] [Abstract][Full Text] [Related]
20. The role of regional chemotherapy in the management of extremity soft tissue malignancies. Smith HG; Hayes AJ Eur J Surg Oncol; 2016 Jan; 42(1):7-17. PubMed ID: 26382102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]